Two of Australia’s leading life sciences and biotech associations have called on all political parties to address the challenges of commercialising locally developed products and services as an election...
Key to securing Australia’s high standard of living is in diversifying our economy from one that is skewed toward commodity export and focus more to value-adding. It will mean...
Australia has the potential to become one of the world’s leading suppliers of cancer-fighting cell therapy treatments, but our leadership must make some bold decisions if we are to...
Brisbane-based vaccine patch company Vaxxas is developing the first room temperature-stable needleless vaccine for one of the world’s most common cold-like diseases, weeks after launching efforts to raise $100...
A $28.5 million commercialisation boost will soon be available to MedTechs fighting heart disease and diabetes under the latest round of a Medical Research Future Fund program. The second...
A new BioTech hub located at La Trobe University’s Melbourne campus has launched, offering world-class wet lab facilities to early-stage companies looking to commercialise their research. The $8 million...
The Australian biotech sector is at an “inflection point” and is ready to work with the federal government on its Future Made in Australia plan, and other critical policies,...
Brisbane-based startup Gelomics, which technology to support the cultivation of synthetic tissue, has completed a $2.2 million pre-seed capital raise with the support of local investors, including the state-owned...
A national BioTech incubator backed by the Medical Research Future Fund has launched its first funding round for innovative health technologies that promise to improve the lives of people...
A wearable “lab-on-a-chip” solution for hormone monitoring, a gum disease vaccine and technology for creating 3D models of human brain tissue are among the ideas that have piqued the...